BlossomHill Therapeutics priced its IPO at $16 a share, raising $150 million with J.P
As seen on the 24/7 Wall St. homepage on August 7, 2026.
BlossomHill Therapeutics, Inc.
BLSM · Nasdaq
$16 / share
$150M raise
9,375,000 shares
Priced at $16 for a $150M Nasdaq debut
BlossomHill Therapeutics priced its IPO at $16 a share, raising $150 million with J.P. Morgan and Leerink leading the book. A deal that size for a precision oncology developer is a real test of how far the reopened biotech window extends.
Mentioned: BLSM